tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Revenue

Compare
17 Followers

Prescient Therapeutics Limited Revenue

Prescient Therapeutics Limited had a revenue of 0.00 in the quarter ending Dec 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 3.11M, Increased -28.65%. In the fiscal year ending Jun 30, 2025, Prescient Therapeutics Limited had annual revenue of 4.36M with 17.36% growth.
Revenue (ttm)
3.11M
Revenue Growth
P/S Ratio
14.00
Revenue/Employee
AU$1,452,132
Employees
3
Market Cap
AU$60.99M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2025
4.36M644.40K+17.36%
Jun 30, 2024
3.71M1.28M+52.88%
Jun 30, 2023
2.43M539.00K+28.53%
Jun 30, 2022
1.89M704.00K+59.41%
Jun 30, 2021
1.19M156.00K+15.16%
Jun 30, 2020
1.03M-619.00K-37.56%
Jun 30, 2019
1.65M708.23K+75.36%
Jun 30, 2018
939.77K-284.23K-23.22%
Jun 30, 2017
1.22M